Soluble Nogo-A in CSF is not a useful biomarker for multiple sclerosis.
Krzysztof
K
Selmaj
Anna
A
Jurewicz
Mariola
M
Matysiak
Cedric S
CS
Raine
D000906:Antibodies; D000918:Antibody Specificity / Q000276:immunology; D016477:Artifacts; D015415:Biomarkers / Q000032:analysis / Q000134:cerebrospinal fluid; D006801:Humans; D007150:Immunohistochemistry / Q000379:methods*; D008970:Molecular Weight; D009103:Multiple Sclerosis / Q000134:cerebrospinal fluid* / Q000175:diagnosis* / Q000276:immunology; D009185:Myelin Proteins / Q000032:analysis / Q000134:cerebrospinal fluid* / Q000276:immunology; D000070798:Nogo Proteins; D010446:Peptide Fragments / Q000134:cerebrospinal fluid / Q000276:immunology; D011237:Predictive Value of Tests; D015203:Reproducibility of Results; D013194:Staining and Labeling / Q000379:methods
D000906:Antibodies; D015415:Biomarkers; D009185:Myelin Proteins; D000070798:Nogo Proteins; D010446:Peptide Fragments; C000603199:RTN4 protein, human